This bill directs the Commandant of the Coast Guard to update Coast Guard policy on using medication to treat drug overdoses, including naloxone and similar medicines for opioid and fentanyl overdoses. It requires naloxone or similar medication to be available on all Coast Guard installations and in each operational environment. The bill requires the Coast Guard to join the tracking system established under section 706 of the National Defense Authorization Act for Fiscal Year 2024 (10 U.S.C. 1090 note) within one year after enactment or after that tracking system is established. It also requires a memorandum of understanding between the Secretary of the department in which the Coast Guard operates (when not operating as a service in the Navy) and the Secretary of Defense to facilitate access to that tracking system. The Commandant must brief two congressional committees within two years about use of naloxone and opioids in the Coast Guard, including progress implementing the updated policy, the prevalence and incidence of illegal fentanyl and other controlled substances over the prior five years, substance-abuse mitigation processes, the status of the required memorandum, and a review of instances where naloxone or similar medication was used in the prior five years. The bill includes a privacy compliance requirement for these activities.
The bill also amends section 70503(a) of title 46, United States Code, adjusting the statutory wording related to controlled substances on board covered vessels. Changes include replacing introductory phrasing, revising paragraph (1) to list manufacturing, distributing, possessing with intent to manufacture or distribute, or placing a controlled substance on board a covered vessel with intent to manufacture or distribute, and inserting the phrase "on board a covered vessel" or "while on board a covered vessel" into other paragraphs as specified.
No publicly available information on estimated costs or funding levels is included in the bill text.
No publicly available information.
No publicly available information.